🔎 Trials Near Me

Hjem › Crohns sygdom › Washington › Seattle

Crohns sygdom kliniske forsøg i Seattle, WA

11 studier for Crohns sygdom søger deltagere på steder i og omkring Seattle (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

RekruttererFase 3
  • University of Washington ( Site 5115), Seattle
Alder 16 til 80 · Alle køn · Opdateret 2. okt. 2026 · NCT06430801

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

RekruttererFase 2
  • Virginia Mason Hospital and Medical Center /ID# 265574, Seattle
Alder 18 til 75 · Alle køn · Opdateret 25. sep. 2026 · NCT06548542

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

RekruttererFase 2
  • University of Washington Medical Center, Seattle
Alder 18 til 75 · Alle køn · Opdateret 25. sep. 2026 · NCT06233461

Familial Inflammatory Bowel Disease Early Risk

RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
  • Seattle Children's Hospital, Seattle
Alder 0 til 55 · Alle køn · Opdateret 28. aug. 2026 · NCT07791862

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

RekruttererFase 3
  • Seattle Children's Hospital, Seattle
Alder 2 til 17 · Alle køn · Opdateret 24. aug. 2026 · NCT05509777

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

RekruttererFase 4
  • Seattle Children's Hospital, Seattle
Alder 6 til 17 · Alle køn · Opdateret 27. maj 2026 · NCT05781152

A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease

RekruttererFase 3
  • Swedish Cancer Institute, Seattle
  • University of Washington Medical Center - Montlake, Seattle
Alder 18 til 65 · Alle køn · Opdateret 27. maj 2026 · NCT06227910

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

RekruttererFase 2
  • University of Washington, Seattle
Alder 18 til 75 · Alle køn · Opdateret 27. apr. 2026 · NCT06456593

Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)

RekruttererObservationsstudie
  • Seattle Children's Hospital, Seattle
Alder 6 til 21 · Alle køn · Opdateret 24. apr. 2026 · NCT06315179

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

RekruttererFase 2
  • Mirador Therapeutics Selected Site, Silverdale · 17 mi væk
Alder 18 til 80 · Alle køn · Opdateret 12. mar. 2026 · NCT07113522

Reverse-Engineering of Exclusive Enteral Nutrition (RE-EEN) in Crohn's Disease: A Multi-Center Trial

Rekrutterer
  • Seattle Children's Hospital, Seattle
Alder 8 til 21 · Alle køn · Opdateret 12. jun. 2025 · NCT06216899

Crohns sygdom forsøg i andre byer

Andre studier i Seattle

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.